Movement Disorders associated with the serotonin selective reuptake inhibitors.
Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. Stahl SM1.
Potency and selectivity are fundamental pharmacological concepts essential to understanding the basic neuropharmacology and the clinical psychopharmacology of serotonin selective reuptake inhibitors.
2009. 08083. PMID 19289334. ^ Leo RJ (1996). "Movement disorders associated with the serotonin selective reuptake inhibitors". The Journal of Clinical Psychiatry 57 (10): 449–54. doi:10. 4088/JCP. v57n1002. PMID 8909330.